Parkside Financial Bank & Trust’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-89
Closed -$1K 1745
2019
Q4
$1K Hold
89
﹤0.01% 1553
2019
Q3
$1K Hold
89
﹤0.01% 1529
2019
Q2
$1K Buy
89
+57
+178% +$615 ﹤0.01% 1541
2019
Q1
$0 Sell
32
-25
-44% -$372 ﹤0.01% 1693
2018
Q4
$0 Hold
57
﹤0.01% 1633
2018
Q3
$1K Hold
57
﹤0.01% 1469
2018
Q2
$1K Hold
57
﹤0.01% 1466
2018
Q1
$1K Buy
57
+25
+78% +$423 ﹤0.01% 1379
2017
Q4
$0 Buy
+32
New +$482 ﹤0.01% 1548
2017
Q3
Sell
-17
Closed 1591
2017
Q2
$0 Sell
17
-7
-29% -$139 ﹤0.01% 1599
2017
Q1
$1K Buy
24
+3
+14% +$72 ﹤0.01% 1282
2016
Q4
$1K Buy
+21
New +$627 ﹤0.01% 1289

Other funds holding AMAG

Parkside Financial Bank & Trust's AMAG Position: Q1 2020 in Review

Parkside Financial Bank & Trust sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 89 shares — an estimated $1K sold.

Parkside Financial Bank & Trust first reported a position in AMAG in Q4 2016 and held it in 12 quarters. The position peaked at $1K in Q4 2019. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

  • Parkside Financial Bank & Trust reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 89 AMAG Pharmaceuticals shares in Q1 2020, an estimated $1K.
  • Parkside Financial Bank & Trust first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 12 quarters.
  • Parkside Financial Bank & Trust's AMAG Pharmaceuticals position peaked at $1K in Q4 2019.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2020, filed 5 May 2020.